QuickView for TFS-II;jsessionid=FD9D07EA4FEA2E9D62FC365AA7DE59D3;jsessionid=86A2AA8A39E51C0F450049D37E597C04;jsessionid=C1188DFB6C25D0C9A6AAC30CD302840A;jsessionid=3EE1BE0659078BE4544C9F9A84D96BC6;jsessionid=8FD879198FECD95242F85DAF74D784D2;jsessionid=82241AEA0346232EB70BF406738B7B2E;jsessionid=A4F255E8E45F33FDCDCCB27B1DF8C153;jsessionid=8EC814A9FF8C6DB868FAD56FF48F56FD (gene)

1. Thymic stroma and TFII-I: towards new targeted therapies.
2. Proteomic analysis of SRF associated transcription complexes identified TFII-I as modulator of SRF f…
3. Structural basis for evolutionarily conserved interactions between TFIIS and Paf1C.
4. The TFIIS N-terminal domain (TND): a transcription assembly module at the interface of order and dis…
5. Identification of novel regulatory NFAT and TFII-I binding elements in the calbindin-D28k promoter i…

There were no clinical trials for TFS-II;jsessionid=FD9D07EA4FEA2E9D62FC365AA7DE59D3;jsessionid=86A2AA8A39E51C0F450049D37E597C04;jsessionid=C1188DFB6C25D0C9A6AAC30CD302840A;jsessionid=3EE1BE0659078BE4544C9F9A84D96BC6;jsessionid=8FD879198FECD95242F85DAF74D784D2;jsessionid=82241AEA0346232EB70BF406738B7B2E;jsessionid=A4F255E8E45F33FDCDCCB27B1DF8C153;jsessionid=8EC814A9FF8C6DB868FAD56FF48F56FD